{
    "contributors": null,
    "coordinates": null,
    "created_at": "Wed Oct 21 05:54:42 +0000 2015",
    "entities": {
        "hashtags": [
            {
                "indices": [
                    19,
                    29
                ],
                "text": "immunoonc"
            }
        ],
        "symbols": [],
        "urls": [
            {
                "display_url": "twitter.com/novartis/statu\u2026",
                "expanded_url": "https://twitter.com/novartis/status/656705235423916032",
                "indices": [
                    120,
                    143
                ],
                "url": "https://t.co/QJrbQ2sL9v"
            }
        ],
        "user_mentions": [
            {
                "id": 17226612,
                "id_str": "17226612",
                "indices": [
                    0,
                    9
                ],
                "name": "Novartis",
                "screen_name": "Novartis"
            }
        ]
    },
    "favorite_count": 0,
    "favorited": false,
    "geo": null,
    "id": 656710180604776449,
    "id_str": "656710180604776449",
    "in_reply_to_screen_name": "Novartis",
    "in_reply_to_status_id": null,
    "in_reply_to_status_id_str": null,
    "in_reply_to_user_id": 17226612,
    "in_reply_to_user_id_str": "17226612",
    "is_quote_status": true,
    "lang": "en",
    "metadata": {
        "iso_language_code": "en",
        "result_type": "recent"
    },
    "place": null,
    "possibly_sensitive": false,
    "quoted_status": {
        "contributors": null,
        "coordinates": null,
        "created_at": "Wed Oct 21 05:35:03 +0000 2015",
        "entities": {
            "hashtags": [
                {
                    "indices": [
                        99,
                        109
                    ],
                    "text": "immunoonc"
                }
            ],
            "symbols": [],
            "urls": [
                {
                    "display_url": "bit.ly/1W3tgQw",
                    "expanded_url": "http://bit.ly/1W3tgQw",
                    "indices": [
                        110,
                        133
                    ],
                    "url": "https://t.co/qaYBD0kcCv"
                }
            ],
            "user_mentions": []
        },
        "favorite_count": 8,
        "favorited": false,
        "geo": null,
        "id": 656705235423916032,
        "id_str": "656705235423916032",
        "in_reply_to_screen_name": null,
        "in_reply_to_status_id": null,
        "in_reply_to_status_id_str": null,
        "in_reply_to_user_id": null,
        "in_reply_to_user_id_str": null,
        "is_quote_status": false,
        "lang": "en",
        "metadata": {
            "iso_language_code": "en",
            "result_type": "recent"
        },
        "place": null,
        "possibly_sensitive": false,
        "retweet_count": 26,
        "retweeted": false,
        "source": "<a href=\"http://www.hootsuite.com\" rel=\"nofollow\">Hootsuite</a>",
        "text": "NEWS: Novartis broadens immuno-oncology pipeline in agreements with three biotechnology companies: #immunoonc https://t.co/qaYBD0kcCv",
        "truncated": false,
        "user": {
            "contributors_enabled": false,
            "created_at": "Fri Nov 07 04:52:06 +0000 2008",
            "default_profile": false,
            "default_profile_image": false,
            "description": "We provide healthcare solutions that address the evolving needs of patients & societies worldwide. See our community guidelines: http://t.co/ErbRQenyRj",
            "entities": {
                "description": {
                    "urls": [
                        {
                            "display_url": "bit.ly/ZeuuT3",
                            "expanded_url": "http://bit.ly/ZeuuT3",
                            "indices": [
                                129,
                                151
                            ],
                            "url": "http://t.co/ErbRQenyRj"
                        }
                    ]
                },
                "url": {
                    "urls": [
                        {
                            "display_url": "novartis.com",
                            "expanded_url": "http://novartis.com",
                            "indices": [
                                0,
                                22
                            ],
                            "url": "http://t.co/cCcmWeeHSD"
                        }
                    ]
                }
            },
            "favourites_count": 177,
            "follow_request_sent": false,
            "followers_count": 165777,
            "following": false,
            "friends_count": 438,
            "geo_enabled": false,
            "has_extended_profile": false,
            "id": 17226612,
            "id_str": "17226612",
            "is_translation_enabled": false,
            "is_translator": false,
            "lang": "en",
            "listed_count": 2325,
            "location": "140+ countries",
            "name": "Novartis",
            "notifications": false,
            "profile_background_color": "FCB017",
            "profile_background_image_url": "http://pbs.twimg.com/profile_background_images/437780731423518720/KyjfmouP.jpeg",
            "profile_background_image_url_https": "https://pbs.twimg.com/profile_background_images/437780731423518720/KyjfmouP.jpeg",
            "profile_background_tile": false,
            "profile_banner_url": "https://pbs.twimg.com/profile_banners/17226612/1443569879",
            "profile_image_url": "http://pbs.twimg.com/profile_images/537380603239202816/fUQmgECF_normal.png",
            "profile_image_url_https": "https://pbs.twimg.com/profile_images/537380603239202816/fUQmgECF_normal.png",
            "profile_link_color": "E44D16",
            "profile_sidebar_border_color": "FFFFFF",
            "profile_sidebar_fill_color": "F5EBD7",
            "profile_text_color": "634329",
            "profile_use_background_image": false,
            "protected": false,
            "screen_name": "Novartis",
            "statuses_count": 8614,
            "time_zone": "Bern",
            "url": "http://t.co/cCcmWeeHSD",
            "utc_offset": 3600,
            "verified": true
        }
    },
    "quoted_status_id": 656705235423916032,
    "quoted_status_id_str": "656705235423916032",
    "retweet_count": 0,
    "retweeted": false,
    "source": "<a href=\"http://twitter.com/#!/download/ipad\" rel=\"nofollow\">Twitter for iPad</a>",
    "text": "@Novartis broadens #immunoonc pipeline with acquisition of Admune and licensing agreements with XOMA &amp; Palobiofarma https://t.co/QJrbQ2sL9v",
    "truncated": false,
    "user": {
        "contributors_enabled": false,
        "created_at": "Thu Jul 12 17:24:56 +0000 2012",
        "default_profile": true,
        "default_profile_image": false,
        "description": "Pharmaceutical/Biotechnology Professional focused on Oncology. \r\nOpinions are my own",
        "entities": {
            "description": {
                "urls": []
            },
            "url": {
                "urls": [
                    {
                        "display_url": "es.linkedin.com/in/jagasquet",
                        "expanded_url": "http://es.linkedin.com/in/jagasquet",
                        "indices": [
                            0,
                            22
                        ],
                        "url": "http://t.co/vp3JIdZzuF"
                    }
                ]
            }
        },
        "favourites_count": 23,
        "follow_request_sent": false,
        "followers_count": 429,
        "following": false,
        "friends_count": 268,
        "geo_enabled": true,
        "has_extended_profile": false,
        "id": 633978297,
        "id_str": "633978297",
        "is_translation_enabled": false,
        "is_translator": false,
        "lang": "en",
        "listed_count": 39,
        "location": "Barcelona, Spain",
        "name": "Jose Antonio Gasquet",
        "notifications": false,
        "profile_background_color": "C0DEED",
        "profile_background_image_url": "http://abs.twimg.com/images/themes/theme1/bg.png",
        "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme1/bg.png",
        "profile_background_tile": false,
        "profile_image_url": "http://pbs.twimg.com/profile_images/2546173677/by2macf06eid3l83z0eb_normal.jpeg",
        "profile_image_url_https": "https://pbs.twimg.com/profile_images/2546173677/by2macf06eid3l83z0eb_normal.jpeg",
        "profile_link_color": "0084B4",
        "profile_sidebar_border_color": "C0DEED",
        "profile_sidebar_fill_color": "DDEEF6",
        "profile_text_color": "333333",
        "profile_use_background_image": true,
        "protected": false,
        "screen_name": "jagasquet",
        "statuses_count": 2087,
        "time_zone": null,
        "url": "http://t.co/vp3JIdZzuF",
        "utc_offset": null,
        "verified": false
    }
}